These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39185406)

  • 1. Characteristics and impact of infiltration of B-cells from systemic sclerosis patients in a 3D healthy skin model.
    Le Maître M; Guerrier T; Collet A; Derhourhi M; Meneboo JP; Toussaint B; Bonnefond A; Villenet C; Sebda S; Bongiovanni A; Tardivel M; Simon M; Jendoubi M; Daunou B; Largy A; Figeac M; Dubucquoi S; Launay D
    Front Immunol; 2024; 15():1373464. PubMed ID: 39185406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
    François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
    Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
    McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
    Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
    Bhandari R; Ball MS; Martyanov V; Popovich D; Schaafsma E; Han S; ElTanbouly M; Orzechowski NM; Carns M; Arroyo E; Aren K; Hinchcliff M; Whitfield ML; Pioli PA
    Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.
    Brembilla NC; Dufour AM; Alvarez M; Hugues S; Montanari E; Truchetet ME; Lonati P; Fontao L; Gabrielli A; Vettori S; Valentini G; Boehncke WH; Meroni P; Chizzolini C
    Ann Rheum Dis; 2016 Sep; 75(9):1697-705. PubMed ID: 26452537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.
    Russo B; Borowczyk J; Boehncke WH; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
    Arthritis Rheumatol; 2021 Jul; 73(7):1311-1317. PubMed ID: 33497035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts.
    Ueda-Hayakawa I; Hasegawa M; Hamaguchi Y; Takehara K; Fujimoto M
    J Dermatol Sci; 2013 Jan; 69(1):54-60. PubMed ID: 23159281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.
    Agarwal SK; Wu M; Livingston CK; Parks DH; Mayes MD; Arnett FC; Tan FK
    Arthritis Res Ther; 2011 Jan; 13(1):R3. PubMed ID: 21223583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
    Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
    Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
    Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
    Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
    Laurent P; Allard B; Manicki P; Jolivel V; Levionnois E; Jeljeli M; Henrot P; Izotte J; Leleu D; Groppi A; Seneschal J; Constans J; Chizzolini C; Richez C; Duffau P; Lazaro E; Forcade E; Schaeverbeke T; Pradeu T; Batteux F; Blanco P; Contin-Bordes C; Truchetet ME
    Ann Rheum Dis; 2021 Dec; 80(12):1594-1603. PubMed ID: 34285051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
    Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
    J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.